 Todos Medical Ltd has announced preliminary data from a sponsored market research study on the commercial use of Tollovid as a dietary supplement among people with coronavirus COVID-19. The institutional review board-waived study was overseen by Todos majority-owned joint venture 3CL Pharma Ltd. 